Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Probiotics, as Adjuvant Therapy and Preventive Measure on Progression, and Complications of Head and Neck Cancer

Author(s): Carlos Enrique Galeana-Patiño, Mario Isidoro Ortiz, Raquel Cariño-Cortés, Iris Cristina López-Santillán, Javier Castro-Rosas, Carlos Alberto Gómez-Aldapa and Víctor Manuel Muñoz-Pérez*

Volume 24, Issue 12, 2023

Published on: 02 March, 2023

Page: [1504 - 1514] Pages: 11

DOI: 10.2174/1389201024666230213094953

Price: $65

Open Access Journals Promotions 2
conference banner
Abstract

Background: Preclinical and clinical evidence implies that destructive therapies in local and malignant tissue are frequently used on patients with head and neck cancer. Consequently, the microbiome of the treated and adjacent regions is affected. Disruption of the normal microbiome plays an important role not only in the disease progression but also in its emergence, therefore new therapies involving probiotics, prebiotics, and synbiotics have been developed to control or regulate this microbial disruption.

Objective: This review aims to describe the current and potential uses of probiotics at different stages of development of head and neck squamous cell carcinoma, as an adjuvant therapy to prevent common complications such as radiation-induced oral mucositis (RIOM) and its role in other areas.

Methods: Currently, there is no widely effective strategy to treat or prevent this kind of cancer. Surgery, radiation therapy, and chemotherapy are the three main treatments for head and neck cancer. Some therapies can also cause long-term health problems, or complications which might change the way you eat, talk, hear and breathe.

Results: The main uses for which probiotics have been studied are: Prevention and reduction of severity of RIOM, change in dental plaque to reduce dysbiosis, and reduction of complications in post-operated patients. Potential uses of probiotics include the reduction of disease initiation and progression by reducing local inflammation caused by bacteria and other organisms.

Conclusion: The incidence and severity of RIOM may be lessened by probiotics. To establish its uses in additional clinical settings, though, more studies are necessary.

Keywords: Probiotics, head, neck squamous cell carcinoma, microbiome, dysbiosis, mucositis, oral cancer.

« Previous Next »
Graphical Abstract

[1]
Chow, L.Q.M. Head and neck cancer. N. Engl. J. Med., 2020, 382(1), 60-72.
[http://dx.doi.org/10.1056/NEJMra1715715] [PMID: 31893516]
[2]
International Agency for Research on Cancer. WHO classification of head and neck tumours, 4th ed; IARC, 2017.
[3]
Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71(3), 209-249.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[4]
Johnson, D.E.; Burtness, B.; Leemans, C.R.; Lui, V.W.Y.; Bauman, J.E.; Grandis, J.R. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers, 2020, 6(1), 92.
[http://dx.doi.org/10.1038/s41572-020-00224-3] [PMID: 33243986]
[5]
Gugnacki, P.; Sierko, E. Is there an interplay between oral microbiome, head and neck carcinoma and radiation-induced oral mucositis? Cancers , 2021, 13(23), 5902.
[http://dx.doi.org/10.3390/cancers13235902] [PMID: 34885015]
[6]
Chen, S.M.Y.; Krinsky, A.L.; Woolaver, R.A.; Wang, X.; Chen, Z.; Wang, J.H. Tumor immune microenvironment in head and neck cancers. Mol. Carcinog., 2020, 59(7), 766-774.
[http://dx.doi.org/10.1002/mc.23162] [PMID: 32017286]
[7]
Greten, F.R.; Grivennikov, S.I. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity, 2019, 51(1), 27-41.
[http://dx.doi.org/10.1016/j.immuni.2019.06.025] [PMID: 31315034]
[8]
Rossi, T.; Vergara, D.; Fanini, F.; Maffia, M.; Bravaccini, S.; Pirini, F. Microbiota-derived metabolites in tumor progression and metastasis. Int. J. Mol. Sci., 2020, 21(16), 5786.
[http://dx.doi.org/10.3390/ijms21165786] [PMID: 32806665]
[9]
Dhull, A.K.; Atri, R.; Dhankhar, R.; Chauhan, A.K.; Kaushal, V. Major risk factors in head and neck cancer: A retrospective analysis of 12-year experiences. World J. Oncol., 2018, 9(3), 80-84.
[http://dx.doi.org/10.14740/wjon1104w] [PMID: 29988794]
[10]
Rettig, E.M.; D’Souza, G. Epidemiology of head and neck cancer. Surg. Oncol. Clin. N. Am., 2015, 24(3), 379-396.
[http://dx.doi.org/10.1016/j.soc.2015.03.001] [PMID: 25979389]
[11]
Blot, W.J.; McLaughlin, J.K.; Winn, D.M.; Austin, D.F.; Greenberg, R.S.; Preston-Martin, S.; Bernstein, L.; Schoenberg, J.B.; Stemhagen, A.; Fraumeni, J.F. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res., 1988, 48(11), 3282-3287.
[PMID: 3365707]
[12]
Hanioka, T.; Morita, M.; Yamamoto, T.; Inagaki, K.; Wang, P.L.; Ito, H.; Morozumi, T.; Takeshita, T.; Suzuki, N.; Shigeishi, H.; Sugiyama, M.; Ohta, K.; Nagao, T.; Hanada, N.; Ojima, M.; Ogawa, H. Smoking and periodontal microorganisms. Jpn. Dent. Sci. Rev., 2019, 55(1), 88-94.
[http://dx.doi.org/10.1016/j.jdsr.2019.03.002] [PMID: 31049117]
[13]
Gillison, M.L. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck, 2007, 29(8), 779-792.
[http://dx.doi.org/10.1002/hed.20573] [PMID: 17230556]
[14]
La Rosa, G.R.M.; Gattuso, G.; Pedullà, E.; Rapisarda, E.; Nicolosi, D.; Salmeri, M. Association of oral dysbiosis with oral cancer development. Oncol. Lett., 2020, 19(4), 3045-3058.
[http://dx.doi.org/10.3892/ol.2020.11441] [PMID: 32211076]
[15]
Brooks, P.J.; Theruvathu, J.A. DNA adducts from acetaldehyde: Implications for alcohol-related carcinogenesis. Alcohol, 2005, 35(3), 187-193.
[http://dx.doi.org/10.1016/j.alcohol.2005.03.009] [PMID: 16054980]
[16]
Chen, P.H.; Mahmood, Q.; Mariottini, G.L.; Chiang, T.A.; Lee, K.W. Adverse health effects of betel quid and the risk of oral and pharyngeal cancers. BioMed Res. Int., 2017, 2017, 1-25.
[http://dx.doi.org/10.1155/2017/3904098] [PMID: 29376073]
[17]
Ko, A.M.S.; Lee, C.H.; Ko, Y.C. Betel quid-associated cancer: Prevention strategies and targeted treatment. Cancer Lett., 2020, 477, 60-69.
[http://dx.doi.org/10.1016/j.canlet.2020.02.030] [PMID: 32112902]
[18]
Chattopadhyay, I.; Verma, M.; Panda, M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol. Cancer Res. Treat., 2019, 18, 1533033819867354.
[http://dx.doi.org/10.1177/1533033819867354] [PMID: 31370775]
[19]
Wong, I.C.K.; Ng, Y.K.; Lui, V.W.Y. Cancers of the lung, head and neck on the rise: perspectives on the genotoxicity of air Pollution. Chin. J. Cancer, 2014, 33(10), 476.
[http://dx.doi.org/10.5732/cjc.014.10093] [PMID: 25011457]
[20]
Wang, K.; Yu, X.; Tang, Y.J.; Tang, Y.; Liang, X. Obesity: An emerging driver of head and neck cancer. Life Sci., 2019, 233(116687), 116687.
[http://dx.doi.org/10.1016/j.lfs.2019.116687] [PMID: 31348948]
[21]
Stockwell, B.R.; Friedmann Angeli, J.P.; Bayir, H.; Bush, A.I.; Conrad, M.; Dixon, S.J.; Fulda, S.; Gascón, S.; Hatzios, S.K.; Kagan, V.E.; Noel, K.; Jiang, X.; Linkermann, A.; Murphy, M.E.; Overholtzer, M.; Oyagi, A.; Pagnussat, G.C.; Park, J.; Ran, Q.; Rosenfeld, C.S.; Salnikow, K.; Tang, D.; Torti, F.M.; Torti, S.V.; Toyokuni, S.; Woerpel, K.A.; Zhang, D.D. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 2017, 171(2), 273-285.
[http://dx.doi.org/10.1016/j.cell.2017.09.021] [PMID: 28985560]
[22]
Nalepa, G.; Clapp, D.W. Fanconi anaemia and cancer: An intricate relationship. Nat. Rev. Cancer, 2018, 18(3), 168-185.
[http://dx.doi.org/10.1038/nrc.2017.116] [PMID: 29376519]
[23]
Radaic, A.; Kapila, Y.L. The oralome and its dysbiosis: New insights into oral microbiome-host interactions. Comput. Struct. Biotechnol. J., 2021, 19, 1335-1360.
[http://dx.doi.org/10.1016/j.csbj.2021.02.010] [PMID: 33777334]
[24]
Hsiao, J.R.; Chang, C.C.; Lee, W.T.; Huang, C.C.; Ou, C.Y.; Tsai, S.T.; Chen, K.C.; Huang, J.S.; Wong, T.Y.; Lai, Y.H.; Wu, Y.H.; Hsueh, W.T.; Wu, S.Y.; Yen, C.J.; Chang, J.Y.; Lin, C.L.; Weng, Y.L.; Yang, H.C.; Chen, Y.S.; Chang, J.S. The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma. Carcinogenesis, 2018, 39(6), 778-787.
[http://dx.doi.org/10.1093/carcin/bgy053] [PMID: 29668903]
[25]
Hills, R., Jr; Pontefract, B.; Mishcon, H.; Black, C.; Sutton, S.; Theberge, C. Gut microbiome: Profound implications for diet and disease. Nutrients, 2019, 11(7), 1613.
[http://dx.doi.org/10.3390/nu11071613] [PMID: 31315227]
[26]
Jain, T.; Sharma, P.; Are, A.C.; Vickers, S.M.; Dudeja, V. New insights into the cancer-microbiome-immune axis: Decrypting a decade of discoveries. Front. Immunol., 2021, 12, 622064.
[http://dx.doi.org/10.3389/fimmu.2021.622064] [PMID: 33708214]
[27]
Shay, E.; Sangwan, N.; Padmanabhan, R.; Lundy, S.; Burkey, B.; Eng, C. Bacteriome and mycobiome and bacteriome-mycobiome interactions in head and neck squamous cell carcinoma. Oncotarget, 2020, 11(25), 2375-2386.
[http://dx.doi.org/10.18632/oncotarget.27629] [PMID: 32637029]
[28]
Levy, M.; Kolodziejczyk, A.A.; Thaiss, C.A.; Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol., 2017, 17(4), 219-232.
[http://dx.doi.org/10.1038/nri.2017.7] [PMID: 28260787]
[29]
Bandara, H.M.H.N.; Panduwawala, C.P.; Samaranayake, L.P. Biodiversity of the human oral mycobiome in health and disease. Oral Dis., 2019, 25(2), 363-371.
[http://dx.doi.org/10.1111/odi.12899] [PMID: 29786923]
[30]
Martínez, A.; Kuraji, R.; Kapila, Y.L. The human oral virome: Shedding light on the dark matter. Periodontol. 2000, 2021, 87(1), 282-298.
[http://dx.doi.org/10.1111/prd.12396] [PMID: 34463988]
[31]
Tumban, E. A current update on human Papillomavirus-associated head and neck cancers. Viruses, 2019, 11(10), 922.
[http://dx.doi.org/10.3390/v11100922] [PMID: 31600915]
[32]
Timbang, M.R.; Sim, M.W.; Bewley, A.F.; Farwell, D.G.; Mantravadi, A.; Moore, M.G. HPV-related oropharyngeal cancer: A review on burden of the disease and opportunities for prevention and early detection. Hum. Vaccin. Immunother., 2019, 15(7-8), 1920-1928.
[http://dx.doi.org/10.1080/21645515.2019.1600985] [PMID: 31050595]
[33]
Li, Y.; Xu, C. Human Papillomavirus-related cancers. Adv. Exp. Med. Biol., 2017, 1018, 23-34.
[http://dx.doi.org/10.1007/978-981-10-5765-6_3] [PMID: 29052130]
[34]
Wong, K.C.W.; Hui, E.P.; Lo, K.W.; Lam, W.K.J.; Johnson, D.; Li, L.; Tao, Q.; Chan, K.C.A.; To, K.F.; King, A.D.; Ma, B.B.Y.; Chan, A.T.C. Nasopharyngeal carcinoma: An evolving paradigm. Nat. Rev. Clin. Oncol., 2021, 18(11), 679-695.
[http://dx.doi.org/10.1038/s41571-021-00524-x] [PMID: 34194007]
[35]
She, Y.; Nong, X.; Zhang, M.; Wang, M. Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis. PLoS One, 2017, 12(10)e0186860
[http://dx.doi.org/10.1371/journal.pone.0186860] [PMID: 29065191]
[36]
Sajid, M.; Srivastava, S.; Joshi, L.; Bharadwaj, M. Impact of smokeless tobacco-associated bacteriome in oral carcinogenesis. Anaerobe, 2021, 70(102400), 102400.
[http://dx.doi.org/10.1016/j.anaerobe.2021.102400] [PMID: 34090995]
[37]
García-Castillo, V.; Sanhueza, E.; McNerney, E.; Onate, S.A.; García, A. Microbiota dysbiosis: A new piece in the understanding of the carcinogenesis puzzle. J. Med. Microbiol., 2016, 65(12), 1347-1362.
[http://dx.doi.org/10.1099/jmm.0.000371] [PMID: 27902422]
[38]
Schmidt, B.L.; Kuczynski, J.; Bhattacharya, A.; Huey, B.; Corby, P.M.; Queiroz, E.L.S.; Nightingale, K.; Kerr, A.R.; DeLacure, M.D.; Veeramachaneni, R.; Olshen, A.B.; Albertson, D.G. Changes in abundance of oral microbiota associated with oral cancer. PLoS One, 2014, 9(6)e98741
[http://dx.doi.org/10.1371/journal.pone.0098741] [PMID: 24887397]
[39]
Wang, H.; Funchain, P.; Bebek, G.; Altemus, J.; Zhang, H.; Niazi, F.; Peterson, C.; Lee, W.T.; Burkey, B.B.; Eng, C. Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas. Genome Med., 2017, 9(1), 14.
[http://dx.doi.org/10.1186/s13073-017-0405-5] [PMID: 28173873]
[40]
Gallimidi, A.B.; Fischman, S.; Revach, B.; Bulvik, R.; Maliutina, A.; Rubinstein, A.M.; Nussbaum, G.; Elkin, M. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget, 2015, 6(26), 22613-22623.
[http://dx.doi.org/10.18632/oncotarget.4209] [PMID: 26158901]
[41]
Gholizadeh, P.; Eslami, H.; Yousefi, M.; Asgharzadeh, M.; Aghazadeh, M.; Kafil, H.S. Role of oral microbiome on oral cancers, a review. Biomed. Pharmacother., 2016, 84, 552-558.
[http://dx.doi.org/10.1016/j.biopha.2016.09.082] [PMID: 27693964]
[42]
Diaz, P.I.; Dongari-Bagtzoglou, A. Critically appraising the significance of the oral mycobiome. J. Dent. Res., 2021, 100(2), 133-140.
[http://dx.doi.org/10.1177/0022034520956975] [PMID: 32924741]
[43]
Leemans, C.R.; Braakhuis, B.J.M.; Brakenhoff, R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer, 2011, 11(1), 9-22.
[http://dx.doi.org/10.1038/nrc2982] [PMID: 21160525]
[44]
Seitz, H.K.; Stickel, F. Acetaldehyde as an underestimated risk factor for cancer development: Role of genetics in ethanol metabolism. Genes Nutr., 2010, 5(2), 121-128.
[http://dx.doi.org/10.1007/s12263-009-0154-1] [PMID: 19847467]
[45]
Radaic, A.; Ganther, S.; Kamarajan, P.; Grandis, J.; Yom, S.S.; Kapila, Y.L. Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial-based therapeutics. Periodontol. 2000, 2021, 87(1), 76-93.
[http://dx.doi.org/10.1111/prd.12388] [PMID: 34463982]
[46]
Koontongkaew, S. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J. Cancer, 2013, 4(1), 66-83.
[http://dx.doi.org/10.7150/jca.5112] [PMID: 23386906]
[47]
Orlandi, E.; Iacovelli, N.A.; Tombolini, V.; Rancati, T.; Polimeni, A.; De Cecco, L.; Valdagni, R.; De Felice, F. Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer. Oral Oncol., 2019, 99(104453), 104453.
[http://dx.doi.org/10.1016/j.oraloncology.2019.104453] [PMID: 31683170]
[48]
Zagury-Orly, I.; Khaouam, N.; Noujaim, J.; Desrosiers, M.Y.; Maniakas, A. The effect of radiation and chemoradiation therapy on the head and neck mucosal microbiome: A review. Front. Oncol., 2021, 11, 784457.
[http://dx.doi.org/10.3389/fonc.2021.784457] [PMID: 34926301]
[49]
Shah, J.P. Staging for head and neck cancer: Purpose, process and progress. Indian J. Surg. Oncol., 2018, 9(1), 116-120.
[http://dx.doi.org/10.1007/s13193-018-0723-0] [PMID: 29563750]
[50]
Matsubara, V.H.; Ishikawa, K.H.; Ando-Suguimoto, E.S.; Bueno-Silva, B.; Nakamae, A.E.M.; Mayer, M.P.A. Probiotic bacteria alter pattern-recognition receptor expression and cytokine profile in a human macrophage model challenged with Candida albicans and lipopolysaccharide. Front. Microbiol., 2017, 8, 2280.
[http://dx.doi.org/10.3389/fmicb.2017.02280] [PMID: 29238325]
[51]
Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. 2017. Available from: https://www.mhlw.go.jp/file/05-Shingikai-11121000-Iyakushokuhinkyoku-Soumuka/0000197343.pdf
[52]
Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; Calder, P.C.; Sanders, M.E. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol., 2014, 11(8), 506-514.
[http://dx.doi.org/10.1038/nrgastro.2014.66] [PMID: 24912386]
[53]
Legesse Bedada, T.; Feto, T.K.; Awoke, K.S.; Garedew, A.D.; Yifat, F.T.; Birri, D.J. Probiotics for cancer alternative prevention and treatment. Biomed. Pharmacother., 2020, 129(110409), 110409.
[http://dx.doi.org/10.1016/j.biopha.2020.110409] [PMID: 32563987]
[54]
Frei, R.; Akdis, M.; O’Mahony, L. Prebiotics, probiotics, synbiotics, and the immune system. Curr. Opin. Gastroenterol., 2015, 31(2), 153-158.
[http://dx.doi.org/10.1097/MOG.0000000000000151] [PMID: 25594887]
[55]
Tsai, Y.L.; Lin, T.L.; Chang, C.J.; Wu, T.R.; Lai, W.F.; Lu, C.C.; Lai, H.C. Probiotics, prebiotics and amelioration of diseases. J. Biomed. Sci., 2019, 26(1), 3.
[http://dx.doi.org/10.1186/s12929-018-0493-6] [PMID: 30609922]
[56]
Pandey, K.R.; Naik, S.R.; Vakil, B.V. Probiotics, prebiotics and synbiotics- a review. J. Food Sci. Technol., 2015, 52(12), 7577-7587.
[http://dx.doi.org/10.1007/s13197-015-1921-1] [PMID: 26604335]
[57]
Swanson, K.S.; Gibson, G.R.; Hutkins, R.; Reimer, R.A.; Reid, G.; Verbeke, K.; Scott, K.P.; Holscher, H.D.; Azad, M.B.; Delzenne, N.M.; Sanders, M.E. The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol., 2020, 17(11), 687-701.
[http://dx.doi.org/10.1038/s41575-020-0344-2] [PMID: 32826966]
[58]
Taherian, M.; Mahin Samadi, P.; Rastegar, H.; Faramarzi, M.A.; Rostami-Nejad, M.; Yazdi, M.H.; Rezaei-Tavirani, M.; Yazdi, Z. An overview on probiotics as an alternative strategy for prevention and treatment of human diseases. Iran. J. Pharm. Res., 2019, 18(Suppl. 1), 31-50.
[http://dx.doi.org/10.22037/ijpr.2020.112232.13620] [PMID: 32802088]
[59]
Jeppsson, B.; Mangell, P.; Thorlacius, H. Use of probiotics as prophylaxis for postoperative infections. Nutrients, 2011, 3(5), 604-612.
[http://dx.doi.org/10.3390/nu3050604] [PMID: 22254113]
[60]
Lee, E.S.; Song, E.J.; Nam, Y.D.; Lee, S.Y. Probiotics in human health and disease: From nutribiotics to pharmabiotics. J. Microbiol., 2018, 56(11), 773-782.
[http://dx.doi.org/10.1007/s12275-018-8293-y] [PMID: 30353462]
[61]
Jayaraj, R.; Kumaraswamy, C.; Shetty, S.; Raymond, G.; Ram, M.R.; Govind, S.K.; Chandramoorthy, H.C.; Shaw, P. Clinical approaches to interpreting the findings of systematic review and meta-analysis of the effectiveness of probiotics in the prevention and treatment of cancer therapy-induced oral mucositis (CTIOM). Oral Oncol., 2020, 104(104622), 104622.
[http://dx.doi.org/10.1016/j.oraloncology.2020.104622] [PMID: 32115371]
[62]
Shu, Z.; Li, P.; Yu, B.; Huang, S.; Chen, Y. The effectiveness of probiotics in prevention and treatment of cancer therapy-induced oral mucositis: A systematic review and meta-analysis. Oral Oncol., 2020, 102(104559), 104559.
[http://dx.doi.org/10.1016/j.oraloncology.2019.104559] [PMID: 31923856]
[63]
Aghazadeh, Z.; Pouralibaba, F.; Yari Khosroushahi, A. The prophylactic effect of Acetobacter syzygii probiotic species against squamous cell carcinoma. J. Dent. Res. Dent. Clin. Dent. Prospect., 2017, 11(4), 208-214.
[http://dx.doi.org/10.15171/joddd.2017.037] [PMID: 29354246]
[64]
Asoudeh-Fard, A.; Barzegari, A.; Dehnad, A.; Bastani, S.; Golchin, A.; Omidi, Y. Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signalling pathways. Bioimpacts, 2017, 7(3), 193-198.
[http://dx.doi.org/10.15171/bi.2017.22] [PMID: 29159146]
[65]
Wang, L.; Wang, Y.; Li, Q.; Tian, K.; Xu, L.; Liu, G.; Guo, C. Exopolysaccharide, isolated from a novel strain Bifidobacterium breve lw01 possess an anticancer effect on head and neck cancer - genetic and biochemical evidences. Front. Microbiol., 2019, 10, 1044.
[http://dx.doi.org/10.3389/fmicb.2019.01044] [PMID: 31143171]
[66]
Cheng, Z.; Xu, H.; Wang, X.; Liu, Z. Lactobacillus raises in vitro anticancer effect of geniposide in HSC 3 human oral squamous cell carcinoma cells. Exp. Ther. Med., 2017, 14(5), 4586-4594.
[http://dx.doi.org/10.3892/etm.2017.5105] [PMID: 29104666]
[67]
Radaic, A.; Ye, C.; Parks, B.; Gao, L.; Kuraji, R.; Malone, E.; Kamarajan, P.; Zhan, L.; Kapila, Y.L. Modulation of pathogenic oral biofilms towards health with nisin probiotic. J. Oral Microbiol., 2020, 12(1), 1809302.
[http://dx.doi.org/10.1080/20002297.2020.1809302] [PMID: 32944159]
[68]
Carvalho, R.; Vaz, A.; Pereira, F.L.; Dorella, F.; Aguiar, E.; Chatel, J.M.; Bermudez, L.; Langella, P.; Fernandes, G.; Figueiredo, H.; Goes-Neto, A.; Azevedo, V. Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. Sci. Rep., 2018, 8(1), 15072.
[http://dx.doi.org/10.1038/s41598-018-33469-w] [PMID: 30305667]
[69]
Zhang, M.; Wang, F.; Jiang, L.; Liu, R.; Zhang, L.; Lei, X.; Li, J.; Jiang, J.; Guo, H.; Fang, B.; Zhao, L.; Ren, F. Lactobacillus salivarius REN inhibits rat oral cancer induced by 4-nitroquioline 1-oxide. Cancer Prev. Res., 2013, 6(7), 686-694.
[http://dx.doi.org/10.1158/1940-6207.CAPR-12-0427] [PMID: 23658366]
[70]
Sharma, A.; Rath, G.K.; Chaudhary, S.P.; Thakar, A.; Mohanti, B.K.; Bahadur, S. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study. Eur. J. Cancer, 2012, 48(6), 875-881.
[http://dx.doi.org/10.1016/j.ejca.2011.06.010] [PMID: 21741230]
[71]
Jiang, C.; Wang, H.; Xia, C.; Dong, Q.; Chen, E.; Qiu, Y.; Su, Y.; Xie, H.; Zeng, L.; Kuang, J.; Ao, F.; Gong, X.; Li, J.; Chen, T. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma. Cancer, 2019, 125(7), 1081-1090.
[http://dx.doi.org/10.1002/cncr.31907] [PMID: 30521105]
[72]
Xia, C.; Jiang, C.; Li, W.; Wei, J.; Hong, H.; Li, J.; Feng, L.; Wei, H.; Xin, H.; Chen, T. A phase II randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma. Front. Immunol., 2021, 12, 618150.
[http://dx.doi.org/10.3389/fimmu.2021.618150] [PMID: 33841399]
[73]
Limaye, S.A.; Haddad, R.I.; Cilli, F.; Sonis, S.T.; Colevas, A.D.; Brennan, M.T.; Hu, K.S.; Murphy, B.A. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer, 2013, 119(24), 4268-4276.
[http://dx.doi.org/10.1002/cncr.28365] [PMID: 24114811]
[74]
Sharma, A.; Tilak, T.; Bakhshi, S.; Raina, V.; Kumar, L.; Chaudhary, S.; Sahoo, R.; Gupta, R.; Thulkar, S. Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation. ESMO Open, 2016, 1(6)e000138
[http://dx.doi.org/10.1136/esmoopen-2016-000138] [PMID: 28848667]
[75]
Doppalapudi, R.; Vundavalli, S.; Prabhat, M.P. Effect of probiotic bacteria on oral Candida in head- and neck-radiotherapy patients: A randomized clinical trial. J. Cancer Res. Ther., 2020, 16(3), 470-477.
[http://dx.doi.org/10.4103/jcrt.JCRT_334_18] [PMID: 32719253]
[76]
Vesty, A.; Gear, K.; Boutell, S.; Taylor, M.W.; Douglas, R.G.; Biswas, K. Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: A pilot study. Sci. Rep., 2020, 10(1), 13201.
[http://dx.doi.org/10.1038/s41598-020-70024-y] [PMID: 32764634]
[77]
Lages, P.C.; Generoso, S.V.; Correia, M.I.T.D. Postoperative symbiotic in patients with head and neck cancer: A double-blind randomised trial. Br. J. Nutr., 2018, 119(2), 190-195.
[http://dx.doi.org/10.1017/S0007114517003403] [PMID: 29277158]
[78]
Gunduz, M.; Murakami, D.; Gunduz, I.; Tamagawa, S.; Hiraoka, M.; Sugita, G.; Hotomi, M. Recurrent bacterial translocation from gut and sepsis in head and neck cancer patients and its prevention by probiotics. Med. Hypotheses, 2018, 120, 124-127.
[http://dx.doi.org/10.1016/j.mehy.2018.08.020] [PMID: 30220331]
[79]
Chowdhury, A.H.; Adiamah, A.; Kushairi, A.; Varadhan, K.K.; Krznaric, Z.; Kulkarni, A.D.; Neal, K.R.; Lobo, D.N. Perioperative probiotics or synbiotics in adults undergoing elective abdominal surgery: A systematic review and meta-analysis of randomized controlled trials. Ann. Surg., 2020, 271(6), 1036-1047.
[http://dx.doi.org/10.1097/SLA.0000000000003581] [PMID: 31469748]
[80]
Yeh, K.Y.; Wang, H.M.; Chang, J.W.C.; Huang, J.S.; Lai, C.H.; Lan, Y.J.; Wu, T.H.; Chang, P.H.; Wang, H.; Wu, C.J.; Hsia, S.; Wang, C.H. Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 2013, 116(1), 41-48.
[http://dx.doi.org/10.1016/j.oooo.2013.01.015] [PMID: 23562359]

Rights & Permissions Print Cite
Article Metrics
42
2
1
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy